Basak, Grzegorz W., Mikala, Gabor, Koristek, Zdenek ORCID: 0000-0002-0478-854X, Jaksic, Ozren, Basic-Kinda, Sandra, Cegledi, Andrea, Reti, Marienn, Masszi, Tamas ORCID: 0000-0003-2322-9863, Mayer, Jiri, Giebel, Sebastian ORCID: 0000-0002-4827-4401, Huebel, Kai, Labar, Boris and Wiktor-Jedrzejczak, Wieslaw (2011). Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late. Leuk. Lymphoma, 52 (9). S. 1711 - 1720. LONDON: INFORMA HEALTHCARE. ISSN 1042-8194

Full text not available from this repository.

Abstract

Plerixafor can rescue the outcome of failing chemotherapy-based stem cell mobilization. However, the optimal time for plerixafor injection in this setting has not been determined. This was investigated by retrospective analysis of data from 48 mobilizations with plerixafor, chemotherapy, and granulocyte-colony stimulating factor (G-CSF). The required yield of 2.0 x 10(6) CD34+ cells/kg was collected from 71% of patients; the median total yield was 4.1 x 10(6) CD34+ cells/kg. Patients to whom plerixafor was administered late (>= 15 days) after chemotherapy, after a long duration (>= 13 days) of treatment with G-CSF, or when the white blood cell count was high (>= 20 x 10(9)/L) were mobilized as efficiently as other patients. Plerixafor was shown to rescue mobilizations at a comparable rate in patients with critically low levels of peripheral blood CD34+ cells (53/mL) and those with higher concentrations. These data suggest that late administration of plerixafor in the course of chemotherapy-based mobilization does not contribute to the failure of this strategy.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Basak, Grzegorz W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mikala, GaborUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Koristek, ZdenekUNSPECIFIEDorcid.org/0000-0002-0478-854XUNSPECIFIED
Jaksic, OzrenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Basic-Kinda, SandraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cegledi, AndreaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Reti, MariennUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Masszi, TamasUNSPECIFIEDorcid.org/0000-0003-2322-9863UNSPECIFIED
Mayer, JiriUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Giebel, SebastianUNSPECIFIEDorcid.org/0000-0002-4827-4401UNSPECIFIED
Huebel, KaiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Labar, BorisUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wiktor-Jedrzejczak, WieslawUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-490085
DOI: 10.3109/10428194.2011.578312
Journal or Publication Title: Leuk. Lymphoma
Volume: 52
Number: 9
Page Range: S. 1711 - 1720
Date: 2011
Publisher: INFORMA HEALTHCARE
Place of Publication: LONDON
ISSN: 1042-8194
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
COLONY-STIMULATING FACTOR; MULTIPLE-MYELOMA; CXCR4 ANTAGONIST; COLLECTION; AMD3100; TRANSPLANTATION; STRATEGIES; VOLUNTEERSMultiple languages
Oncology; HematologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/49008

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item